Joseph Tucker

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.

BioAlberta is a private, not-for-profit industry association that represents and promotes the life sciences industry in Alberta, Canada. The non-profit company is based in Edmonton, Canada. With over 230 members, BioAlberta facilitates economic diversification, investment attraction, and job growth in specialized sectors such as pharmaceuticals, medical devices, natural health products, as well as environmental, agricultural, and industrial biotechnology. The organization provides networking and educational events, and delivers policy options to governments. BioAlberta's activities are focused on advocacy, promotion, marketing, and networking, and industry development. The CEO of the Canadian company is Robb Stoddard.

SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada.

VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA.

MagicMed Industries, Inc. intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal. The company was founded by Joseph Tucker, Peter Facchini, and Jillian Hagel on May 26, 2020 and is headquartered in Vancouver, Canada.